A CDC Vital Signs report has taken on the changing epidemiology of Clostridium difficile infections, showing a dramatic increase in prevalence and mortality associated with the disease in the past decade. Most at risk for developing the serious gastrointestinal infection are patients taking antibiotics who also receive care at any kind of medical facility.
Several weeks ago, CDDEP launched a new series to elucidate trends in global health through graphs, charts, and other visualizations. This week's graphic breaks down trends in global macrolide antibiotic sales, and offers some interesting insights regarding macrolide use in the United States.
The Economist interviewed friend and collaborator Petra Klepac on optimal vaccination strategies, asking, under what circumstances does it make good economic and epidemiological sense to invest your resources in vaccinating neighboring communities?